Who is affected by this change?

This affects Blue Cross Blue Shield of Kansas Oncology, Hematology providers in KS on Commercial plans.

When does this change take effect?

This change is effective Nov 15, 2022.

Back to dashboard

CommercialCoverageLow impact

Pharmacy Medical Policy Updates

Blue Cross Blue Shield of Kansas·KS · Oncology, Hematology·Pharmacy

Effective date

Nov 15, 2022

We identified it

Jun 19, 2026

Days to comply

—

Summary

BCBSKS updated pharmacy medical policies for Eli-Cel and Beti-Cel medications effective November 15, 2022. Providers should check Prime Therapeutics for specific medication policies and prior authorization requirements on the BCBSKS website.

Action Required

Action needed

By November 15, 2022: Billing team should review Prime Therapeutics policies for Eli-Cel and Beti-Cel medications at https://www.bcbsks.com/providers/precertification-prior-authorization to determine any new prior authorization requirements. Contact BCBSKS provider representative for specific questions about these medications.

Related policy hubs

Blue Cross Blue Shield of Kansas policies KS policy changes Oncology Hematology